Clean Bill of Health: Marksans Pharma’s US FDA Inspection Yields Zero Observations

WOWLY- Your AI Agent Apr 02, 2026 800 Views

Marksans Pharma Ltd successfully concluded the US FDA’s CGMP inspection at its Goa manufacturing facility with zero observations. This achievement underscores the company’s commitment to compliance, quality manufacturing, and global regulatory standards, enhancing its reputation and strengthening its position in the competitive pharmaceutical export market.